Oppenheimer Analyst Reaffirms Outperform Rating for Olema Pharmaceuticals
Oppenheimer analyst Matthew Biegler has once again endorsed Olema Pharmaceuticals (NASDAQ: OLMA) with a positive Outperform rating and a price ...
© 2024 Stocks Today
Tag: OLMA
Citigroup Analyst Initiates Coverage on Olema Pharmaceuticals with a Buy Rating and 20 Price Target
On January 30, 2024, Yigal Nochomovitz, an esteemed analyst at Citigroup, made a significant move by initiating coverage on Olema ...
Vontobel Holding Ltd. Reduces Stake in Olema Pharmaceuticals: Examining Challenges and Potential for Growth
Vontobel Holding Ltd., a renowned Swiss international financial service company, has made significant changes to its investment portfolio by reducing ...
Don't Miss It
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape